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Abstract
Background: The analysis and interpretation of change in cognitive function test scores after
Coronary Artery Bypass Grafting (CABG) present considerable statistical challenges. Application of
hierarchical linear statistical models can estimate the effects of a surgical intervention on the time
course of multiple biomarkers.

Methods: We use an “analyze then summarize” approach whereby we estimate the intervention
effects separately for each cognitive test and then pool them, taking appropriate account of their
statistical correlations. The model accounts for dropouts at follow-up, the chance of which may be
related to past cognitive score, by implicitly imputing the missing data from individuals’ past scores
and group patterns.
We apply this approach to a study of the effects of CABG on the time course of cognitive
function as measured by 16 separate neuropsychological test scores, clustered into 8 cognitive
domains. The study includes measurements on 140 CABG patients and 92 nonsurgical controls at
baseline, and 3, 12, and 36 months. Including a nonsurgical control group allows comparison of
changes in cognition over time between the surgery group and patients with similar risk factors,
controlling for potential effects of aging and vascular disease.

Results: CABG patients have longitudinal changes from baseline in cognitive function similar to
those observed for nonsurgical controls. Any small differences tend to favor greater improvement in
CABG patients than in the nonsurgical controls.

Conclusions: The methods used have application to a wide range of intervention studies in which
multiple biomarkers are followed over time to quantify health effects. Software to implement the
methods in commonly used statistical packages is available from the authors at
http://www.biostat.jhsph.edu/research/software.shtml .
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Introduction
The establishment of an association between the surgical procedure (CABG), and either shortor long-term cognitive change has been hampered by the use of studies involving only the CABG
population, without comparison with suitable control groups. Short-term studies have compared the
outcomes of CABG with those of other surgical procedures, such as orthopedic operations (1), but
these controls do not have the high incidence of underlying risk factors for vascular disease that
occurs in the CABG population. The lack of appropriate controls is particularly problematic for
interpretation of studies concerning long-term cognitive performance after CABG, where possible
decline could be related to the surgical procedure, age-related change, underlying cerebrovascular
disease (2), or a combination of these factors.
We are involved in an ongoing study that allows comparison of patients receiving CABG with a
group of individuals that have established coronary artery disease, but do not have surgery; these
nonsurgical controls (NSC) have an incidence of risk factors for vascular disease similar to that of
the CABG group. In the accompanying paper by Selnes et al. we compare the longitudinal
performance of these two groups at baseline and 3, 12, and 36 months post surgery or enrollment.
A first question is whether the pattern of cognitive change in the CABG group differs from that
observed in the NSC group. A second question is whether any differences are likely caused by the
surgery.
Determining whether there are different short-term or long-term declines in cognitive function for
CABG as compared to a control group is challenging for at least three reasons. First, cognitive
function is a multidimensional construct, which is assayed by numerous cognitive tests designed to
assess different aspects of cognition such as memory, language, or executive function. Second,
measurements of cognitive function over time will be affected by several factors, including practice
effects, age-related change, error of measurement, and any intervention effect. Finally, the
demonstrated medical efficacy of CABG makes a randomized treatment trial comparing surgical
and nonsurgical treatments difficult.
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In this paper, we discuss a hierarchical statistical model that can be used to quantify differences
in change in cognitive function over time between the CABG and control groups. We use the
statistical model to estimate the average cognitive function over time for the surgery and control
groups, after adjusting for known differences in potential confounding variables, specifically age,
gender, education, and the presence of symptoms of depression.
After a summary of the main ideas for hierarchical linear models, we estimate both short-term
and long-term effects of CABG on cognitive function, while controlling for differences between the
two populations at baseline and differences due to age, gender, education, and level of depressive
symptoms. Finally, we combine the estimates of the surgery effects across many measures into
domain-specific estimates of group differences. This method relies upon prior knowledge about the
domains of cognitive function measured by each test.
The statistical approaches we have used for evaluation of prospective, longitudinal data
comparing patients after CABG with a nonsurgical control group have general applicability to other
clinical studies in which the goal is the evaluation of the impact of an intervention.
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Methods

Study Design

This is an observational study of 140 patients undergoing CABG and 92 nonsurgical cardiac
controls. Surgical patients (CABG) and nonsurgical controls were recruited from September 1997
through March 1999 at the Johns Hopkins Cardiac Unit. The NSC group was identified by Johns
Hopkins cardiologists as potential patients who were diagnosed with coronary artery disease by
cardiac catheterization.
Study participants were administered a battery of standardized neuropsychological tests at
baseline, and 3, 12 and 36 months. Appendix 1 presents the 16 cognitive measures that are
organized into 8 domains of cognitive function based principally on face validity. Patients were also
administered The Center for Epidemiological Studies Depression scale (CES-D) at baseline and
follow-up (3), in order to adjust cognitive test scores for possible effects of depressed mood. See
the accompanying paper by Selnes et al. (2004) for a detailed description of the patient population
and study design.

Hierarchical Linear Statistical Model (4)

This section describes a now standard statistical model designed to capture the key
components of the change in cognitive function over time for the individuals in our study and for
their population, and to compare the typical change for persons who do and do not receive an
intervention such as CABG. As an example we focus on a single cognitive domain, Verbal Memory;
below we present a method for pooling results across tests to obtain the domain values.
The model is specified by the following assumptions:
-

Each person has a unique level and time trend of cognitive function.
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-

Over periods of time, such as a few years, true cognitive function changes gradually and

can be approximated by a smooth function of time, such as a low order polynomial (5).
-

The intervention may affect people in the short term by immediately increasing or

decreasing their function; and over the longer term by changing their pre-intervention trend. The
short-term and long-term effects of intervention may vary across individuals.
-

The level of cognitive function is influenced, possibly in a nonlinear way, by other factors

such as age, gender, education, and level of depressive symptoms.
-

Measurements of cognitive function are subject to a practice effect whereby a study

participant’s scores on quantitative tests could improve with repetition, particularly from the first to
second testing, absent a change in actual cognitive function level.
Below is presented a schematic of this model. The goal is to estimate the effects of an
intervention from a dataset comprising repeated observations on cognitive tests over time for
persons who have received the intervention and other similar persons who have not.

Intervention

Covariates:
Age,Gender,
Education,
CESD

True
cognitive
function

Measured
Cognitive
Performance

Practice effect

Schematic representation of the statistical model for estimating the effects of an intervention
(e.g., CABG) on a single measure of cognitive function. Ovals represent unobserved
variables. See Appendix 2 for details.
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The model illustrated above is made precise by the equations in Appendix 2. This model is
implemented for a single cognitive function measure by using random effects software available in
most standard statistical software packages.
The proposed model has two degrees of freedom to quantify a possible effect of CABG: the rise
from 0 to 3 months (short-term, or learning effect); and a difference in the slope from 3 to 36 months
(long-term effect). We use a Wald test (6) of the null hypothesis of no CABG effect by testing
whether both are equal to 0.0.
The model has the ability to reduce bias caused by differential missing data between the groups
when dropout is related to past cognitive score, resulting in individuals seen at all follow-up points
having a different distribution of scores to the entire group. The model uses information from
previous time-points and group patterns to internally impute missing data at later follow-up points
and make more precise estimates of the true group means.

Estimating Natural Heterogeneity

In addition to estimating the mean curves for each intervention group, the model is used to
estimate the variance among the true levels and trends in a cognitive test score among persons
within groups (5). We allow this degree of variation to differ between the two intervention groups.
Evidence for this natural variation derives from the correlation among repeated observations on
each individual.

Pooling Intervention Effects Across Cognitive Measures

The hierarchical model in Appendix 2 is estimated separately for each of the 16 measures of
cognitive function. This produces, for each measure, a short- and long-term intervention effect
estimate and a 2x2 covariance matrix that quantifies their statistical error. We estimate the mean
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short- or long-term “effect” for a domain as the mean of the effects for the tests in that domain.
Since the multiple test scores for an individual are correlated with one another, estimates of the
CABG effects for the different measures are also correlated. To correctly estimate the standard
errors of these domain-specific or overall effects, we must take this correlation into account. We
use bootstrapping (7), re-sampling individuals, to estimate the joint covariance matrix among the 16
pairs of intervention effect estimates and to obtain valid standard errors for the domain and overall
intervention effect estimates. We draw with replacement a random sample of 140 CABG and 92
NSC subjects, refit all 16 models to get test-specific short- and long-term effect estimates, average
these to obtain domain and overall effect estimates, and then repeat this process 1000 times. The
variance among the 1000 bootstrapped replicates of the domain and overall effect estimates gives
a valid estimate of statistical uncertainty, used to calculate the confidence intervals of the effect
estimates, as it takes appropriate account of the correlation among multiple cognitive test scores for
the same individual.
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Results

The analyses were performed using the R software package (8).
Figure 1 is a spaghetti plot of the standardized and covariate-adjusted data for the Verbal
Memory domain stratified by intervention group. The cognitive test scores were standardized such
that the NSC group had a mean score of zero and standard deviation of one at baseline, and were
adjusted for age, gender, education level and depressive symptoms. The Verbal Memory domain is
made up of the total score, delayed recall (trial 8), retention score and corrected recognition from
the Rey Auditory Verbal Learning Test (9). The group mean scores at each time are also shown. A
learning effect is evidenced by the increase in mean score in both groups from baseline to 3
months. There is little change from 3 to 36 months in the mean response for either group after the
initial rise.
Figure 2 illustrates the steps taken in fitting the hierarchical model detailed in Appendix 2 to the
Verbal Memory data. Panel A (upper left) shows the mean Verbal Memory response for each
treatment group and time, adjusted for covariates. Note that at baseline, the CABG group was
nearly 0.4 of a standard deviation below the NSC group, even after correcting for age, gender,
education, and depressive symptoms. At 3 months, both groups increase substantially as would be
expected from a practice effect. There is some narrowing of the group difference. At 12 and 36
months, the means change comparatively little from the 3-month level in either group and although
both decrease slightly, neither go below their baseline scores.
Panel B is obtained from Panel A by subtracting from all times the baseline values separately
for each group to obtain change scores by time and group. Note that each group has the value 0.0
at baseline by definition. This step removes any differences between the two groups that are
constant over time.
Panel C is a plot of the difference between the intervention (CABG) and control group (NSC)
curves in Panel B at each time. These differences are the essential evidence relevant to assessing
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the intervention (CABG) effect, as they show the disparities between the cognitive scores of the
group that has had surgery and a group with similar risk factors that has not. Without this
comparison, we cannot attribute any change in scores for the CABG group to the surgery. They still
require some adjustment, however, because they are averages of observed data and do not take
account of the fact that the number of dropouts may differ between the two groups.
Panel D presents improved estimates of the difference at each time between the CABG and
NSC group curves shown in C. The results in D are obtained from the hierarchical model in
Appendix 2. The small differences in the curves in Panels C and D reflect changes from taking
appropriate account of missing data. In the case of this domain, the CABG patients remaining at 36
months are those with poorer cognitive scores at baseline than the individuals that dropped out,
with the opposite effect in the NSC group, a phenomenon likely to bias the mean group score at 36
months towards lower values. The hierarchical model implicitly imputes the missing data by using
the information for the individuals at previous times and the patterns for their group. The means in
Panel C ignore the missing data and are biased unless the chance of dropping out is unrelated to
past cognitive score, which is an unlikely situation.
Panel D shows evidence of a difference in population mean Verbal Memory value between the
intervention and control groups, with the CABG group having a greater improvement from baseline
than the NSC group, both in the short-term at 3 months and in the long-term at 36 months. The test
of the null hypothesis that both the short- and long-term effects are zero has a p-value of 0.01,
indicating that this hypothesis can be rejected in favor of the CABG group.
Figure 3 shows the estimated difference in the cognitive function time course between the
intervention (CABG) and NSC groups (Panel D in Figure 2 for Verbal Memory) for all 8 of the
cognitive domain measures. The accompanying paper by Selnes et al. (2004) presents the
corresponding figure for the 16 cognitive subtests. The p-values on the plots in Figure 3 again
result from tests of zero difference in the trends over time between the groups and make it clear
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that in this dataset, there is little or no evidence consistent with a detrimental effect of CABG on
cognitive function as measured by these 8 scores.
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Discussion

We have used a hierarchical linear statistical model to quantify the evidence relevant to
assessing whether CABG causes short- or long-term decline in cognitive functioning. Our approach
was to estimate this model separately for each of the cognitive measures and to pool the results
across measures into cognitive domain effects. We take appropriate account of the correlation
among repeated measures for an individual when setting confidence intervals for the average
domain effects.
The findings in this study emphasize the importance of having a control group for at least two
reasons. First, there is strong evidence in both groups of an improvement in the mean score from
baseline to 3 months indicative of a learning effect. In 15 out of the 16 cognitive test measures, the
mean score increased over this initial period in the CABG group. If only the CABG data were
available, what appears to be a learning effect might be mistaken as a benefit of the intervention.
Second, there is a mix of positive and negative trends over the 36 months in the CABG group for
the different cognitive tests and domains. But these trends were statistically different from the
trends observed in the NSC group for only two domain measures and in both cases showed a
positive effect of CABG at 36 months. Hence a trend in the CABG group data should not be
mistaken for evidence of a treatment effect without comparison with controls.
The model described here estimates the average difference between the CABG and control
groups in the change in cognitive function from baseline. We use the model to adjust for baseline
differences between the groups in test scores and for differences over time that are attributable to
demographics and depression symptoms, the latter as measured by the CESD.
However, no model can adjust for unmeasured differences between the two groups that are
more likely to arise in observational studies where subjects choose their treatment in consultation
with their physician rather than having it assigned by a known, random mechanism. Hence, we
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must be cautious in our interpretation of the evidence, asking what other factors might account for
the differences or lack thereof between the two groups.
The hierarchical model allows one to take appropriate account of dropouts, a common
phenomenon in longitudinal studies such as this one. The model includes terms that acknowledge
the correlation among repeated observations for each individual. Having done so, it can internally
impute missing values by predictions based upon the earlier responses and other covariates (5).
Failure to use a model that accounts for within-person correlation can lead to biased estimates of
treatment effects except when the dropout process is independent of the past responses, which is
unlikely.
We have presented an approach to the difficult problem of how to estimate the effect of CABG
on the performance of 16 cognitive measures by first analyzing each of them separately with an
hierarchical model and then pooling the effect estimates to obtain domain effects. We refer to this
as the “analyze then summarize” approach. An alternative is to “summarize then analyze” the data
by using factor analysis (10) or some other method to create summary scores from the 16 test
results and then to use hierarchical models with the summary measures. We prefer our approach
because it produces a separate treatment effect for every measure so that unanticipated patterns
can be discovered. It avoids the difficult problem of how to choose the best summary scores.
Typically, summarization is based upon the correlation among test results at one time and does not
take appropriate account of the longitudinal information.
The methods used here have wide application to a variety of longitudinal studies comparing
intervention groups or groups defined in other ways when the outcome is multivariate. To facilitate
the application of these methods, software to implement the analyses presented here has been
posted to our webpage (http://www.biostat.jhsph.edu/research/software.shtml).
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Fig 1. Spaghetti plots of the standardized and adjusted (for age, gender, education and depressive
symptoms) Verbal Memory scores across time, stratified by treatment group.

Fig 2. Illustration of the steps taken to fit the hierarchical model to the Verbal Memory data; Upper
left Panel A – average curves for each intervention group; Upper right Panel B – average change
from baseline for each intervention group; Lower left Panel C – difference in mean change from
baseline between the CABG and NSC groups; Lower right Panel D – model estimates of group
difference in change from baseline that take appropriate account of missing data.

Fig 3. Model estimates of the difference in cognitive function change between the CABG and NSC
groups over time for all 8 domains, where a positive difference in the solid line indicates a greater
improvement from baseline in the CABG group than in the NSC group. Note that where there is
only one test in a domain, the estimate for that particular test is used instead of bootstrapping.
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Appendix 1: Details on cognitive function tests.
Test names, abbreviations and descriptions, along with the domains that are made up of
them
Test Name
Rey Auditory Verbal
Learning Test
Total score
Delayed recall
(Trial 8)
Retention score
Recognition
(corrected)
Rey Complex Figure
Retention
score (%)
Delayed recall
Rey Complex Figure
Copy
Block Design
Boston Naming Test
(short form)
Grooved Pegboard
Dominant hand
Non-dominant
hand
Trail Making Test – Part A

Written alphabet

Rey Auditory Verbal
Learning Test
Trial 1
Mini-Mental Status
Examination
Attention score
Trail Making Test – Part B

Abbreviation

RVLTTOT
TR8

Description
A word-list learning task assessing verbal
learning, retention and recognition
memory

Domain

Verbal
Memory

RETEN
RECCORR
A measure of ability to recall a complex
visual design previously copied
RCFRET

Visual
Memory

RCFDR
RCFC
BLOCKS
BNT

GPDOM
GPNDOM
TRAILA

WA

TR1

MMATT
TRAILB

A measure of visuospatial abilities
requiring subject to copy a complex visual
design
A measure of visual confrontation naming
requiring subject to name a series of 30
line drawings
Test of motor speed measuring how
quickly subject is able to place 25 keyed
pegs in an array of 5 x 5 holes with
randomly positioned slots
Timed task that requires subject to
connect numbered circles in sequence as
quickly as possible
Timed measure of psychomotor speed in
which subject is asked to write letters of
alphabet as quickly as possible
A word-list learning task assessing verbal
learning, retention and recognition
memory
Attention score from Mini-Mental State
Exam
Timed test of psychomotor speed that
requires participant to connect numbered
and lettered circles alternately in
sequential (numerical and alphabetical)
order

Visuoconstruction

Language

Motor Speed

Psychomotor
Speed

Attention

Executive
Function
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Appendix 2: Hierarchical statistical model for a single biomarker

This appendix specifies the hierarchical linear statistical model to quantify the difference in
average time-curve for intervention and control groups and to estimate an individual’s time curve
acknowledging the natural heterogeneity among persons in the level and trend of the cognitive
functioning. To be precise, we make the following definitions:

ηit – true cognitive function level for person i at time t
µit – true level of cognitive function absent the intervention
Xi = 1 if intervention received and 0 if not

δit – intervention effect for person i at time t
Yit – measurement of cognitive function
Zit – covariate information for including: age, gender, education level, CESD depression
index
Postt = 1 for post-intervention visits and 0 at baseline

βp – change in score from the first to second measurement due to a learning effect

We assume that the true cognitive function level for person i at time t is the sum of their value µit
that would be expected absent the intervention plus an intervention effect δit:

ηit = µit + Xi δit .

(1)

We then assume that the baseline curve can be approximated by a linear function with intercept
and trend that are specific to each person (i):

µit = β0i + β1i t .

(2)

We let the level at baseline β 0i be influenced in possibly non-linear ways by covariates such as
age, gender, education level, and depression symptoms (CESD) and to have a person-specific
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deviation b0i from the population average reflecting other unmeasured influences in cognitive
function.

β0i = β00 + b0i + S(agei) + … + S(CESDi)

(3a)

Similarly, the trends are allowed to vary among persons with each person having his or her own
deviation b1i:

β1i = β10 + b1i.

(3b)

We assume that the treatment effect δ it is also linear with subject-specific intercept δ 0i and
trend δ 1i:

δit = δ0i + δ1it

(4)

We assume that collectively, the intercepts and trends for the cognitive function of time absent
intervention (b0i,b1i) and for the intervention effect (δ0i,δ1i) can be thought of as samples from a
Gaussian distribution with variances Gb and Gd.

Finally, we acknowledge that the measured cognitive test score includes a learning effect
assumed to be roughly constant after the baseline measure plus statistical noise that is assumed to
be independent from one time to the next, that is:
Yit = ηit + Posti βp + εit .

(5)

The model represented by equations (1) - (5) can be readily simplified to deal with the case of a
single group. This reduced model is defined by equations (2), (3) and (5) and includes random
effects (b0i,b1i) only.
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Figure 1
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Figure 2
(A) Mean Verbal memory over time
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